期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis 被引量:8
1
作者 Segundo Moran Marlene López-Sánchez +1 位作者 María del Pilar Milke-García Gustavo Rodríguez-Leal 《World Journal of Gastroenterology》 SCIE CAS 2021年第22期3050-3063,共14页
Minimal hepatic encephalopathy(MHE)corresponds to the earliest stage of hepatic encephalopathy(HE).MHE does not present clinically detectable neurological-psychiatric abnormalities but is characterized by imperceptibl... Minimal hepatic encephalopathy(MHE)corresponds to the earliest stage of hepatic encephalopathy(HE).MHE does not present clinically detectable neurological-psychiatric abnormalities but is characterized by imperceptible neurocognitive alterations detected during routine clinical examination via neuropsychological or psychometrical tests.MHE may affect daily activities and reduce job performance and quality of life.MHE can increase the risk of accidents and may develop into overt encephalopathy,worsening the prognosis of patients with liver cirrhosis.Despite a lack of consensus on the therapeutic indication,interest in finding novel strategies for prevention or reversion has led to numerous clinical trials;their results are the main objective of this review.Many studies address the treatment of MHE,which is mainly based on the strategies and previous management of overt HE.Current alternatives for the management of MHE include measures to maintain nutritional status while avoiding sarcopenia,and manipulation of intestinal microbiota with non-absorbable disaccharides such as lactulose,antibiotics such as rifaximin,and administration of different probiotics.This review analyzes the results of clinical studies that evaluated the effects of different treatments for MHE. 展开更多
关键词 Minimal hepatic encephalopathy SARCOPENIA PROBIOTICS Non-absorbable disaccharides Rifaximin l-ornithine-l-aspartate
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部